229 related articles for article (PubMed ID: 29575979)
1. Importance of the integrated test in the Down's syndrome screening algorithm.
Springer D; Loucky J; Tesner P; Cutka D; Stejskal D; Gregor V; Zima T
J Med Screen; 2018 Sep; 25(3):114-118. PubMed ID: 29575979
[TBL] [Abstract][Full Text] [Related]
2. First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012600. PubMed ID: 28295158
[TBL] [Abstract][Full Text] [Related]
3. SURUSS in perspective.
Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
[TBL] [Abstract][Full Text] [Related]
4. First-trimester or second-trimester screening, or both, for Down's syndrome.
Malone FD; Canick JA; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Bianchi DW; Rudnicka AR; Hackshaw AK; Lambert-Messerlian G; Wald NJ; D'Alton ME;
N Engl J Med; 2005 Nov; 353(19):2001-11. PubMed ID: 16282175
[TBL] [Abstract][Full Text] [Related]
5. SURUSS in perspective.
Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
BJOG; 2004 Jun; 111(6):521-31. PubMed ID: 15198778
[TBL] [Abstract][Full Text] [Related]
6. First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012599. PubMed ID: 28295159
[TBL] [Abstract][Full Text] [Related]
7. First trimester serum tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011975. PubMed ID: 26617074
[TBL] [Abstract][Full Text] [Related]
8. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters.
Wald NJ; Watt HC; Hackshaw AK
N Engl J Med; 1999 Aug; 341(7):461-7. PubMed ID: 10441601
[TBL] [Abstract][Full Text] [Related]
9. Age related detection and false positive rates when screening for Down's syndrome in the first trimester using fetal nuchal translucency and maternal serum free betahCG and PAPP-A.
Spencer K
BJOG; 2001 Oct; 108(10):1043-6. PubMed ID: 11702835
[TBL] [Abstract][Full Text] [Related]
10. Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study.
Crossley JA; Aitken DA; Cameron AD; McBride E; Connor JM
BJOG; 2002 Jun; 109(6):667-76. PubMed ID: 12118646
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of a programme for the prenatal screening for Down's syndrome by ultrasonographic nuchal translucency measurement and serum determinations in the first trimester of pregnancy].
Go AT; Hupkes HW; Lomecky M; Twisk J; Blankenstein JM; van Vugt JM
Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2795-9. PubMed ID: 16385832
[TBL] [Abstract][Full Text] [Related]
12. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
13. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
[TBL] [Abstract][Full Text] [Related]
14. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
[TBL] [Abstract][Full Text] [Related]
15. First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency.
Orlandi F; Damiani G; Hallahan TW; Krantz DA; Macri JN
Ultrasound Obstet Gynecol; 1997 Dec; 10(6):381-6. PubMed ID: 9476320
[TBL] [Abstract][Full Text] [Related]
16. Screening of maternal serum for fetal Down's syndrome in the first trimester.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
[TBL] [Abstract][Full Text] [Related]
17. First trimester, second trimester, and integrated screening for Down's syndrome in China.
Miao ZY; Liu X; Shi TK; Xu Y; Song QH; Tang SH
J Med Screen; 2012 Jun; 19(2):68-71. PubMed ID: 22653574
[TBL] [Abstract][Full Text] [Related]
18. The utility of circulating LHCGR as a predictor of Down's syndrome in early pregnancy.
Chambers AE; Mills WE; Mercadé I; Crovetto F; Crispi F; Bodi LR; Pugia M; Mira A; Lasalvia L; Banerjee S; Casals E; Gratacos E
BMC Pregnancy Childbirth; 2014 Jun; 14():197. PubMed ID: 24906955
[TBL] [Abstract][Full Text] [Related]
19. Introduction of first trimester combined test increases uptake of Down's syndrome screening.
Tringham GM; Nawaz TS; Holding S; Mcfarlane J; Lindow SW
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):95-8. PubMed ID: 21839574
[TBL] [Abstract][Full Text] [Related]
20. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
